Return to Listing

8 result(s) for Other

PI Name Protocol # Title
Gordon Mills STUDY00016113 Molecular Mechanisms of Tumor Evolution and Resistance to Therapy
Rajan Kulkarni STUDY00017648 VAPORHCS/OHSU J: Isolation and analysis of circulating tumor cells (CTCs) and nucleic acids from patient blood specimens
Kerri Winters STUDY00018342 A novel therapeutic intervention to restore health and functioning in persons with chemotherapy-induced peripheral neuropathy
Erika Cottrell STUDY00021282 Understanding the Experience of Adolescent and Young Adult Cancer (AYA Cancer Study)
Richard Maziarz STUDY00021423 A Phase 1/2 Study of RTX-240 as a Monotherapy and in Combination with Pembrolizumab
Christopher Ryan STUDY00021677 [NCI CIRB] NCICOVID - NCI COVID-19 in Cancer Patients Study (N-CCaPS): A Longitudinal Natural History Study
Rebecca Silbermann STUDY00022542 [NCI CIRB] EAA181: Effective Quadruplet Utilization After Treatment Evaluation (EQUATE): A Randomized Phase 3 Trial for Newly Diagnosed Multiple Myeloma Not Intended For Early Autologous Transplantation
Evan Shereck STUDY00023290 [NMDP IRB-MOU] Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for the Treatment of Bone Marrow Failure Diseases

You may also qualify for Phase 1 Program trials.

For more information:
Call: 503-494-1080